Author Archive

Press Coverage Biotechnology Industry Organization (BIO)-Pugatch Consilium report on Intellectual Property Rights and emerging and developing economies

Posted by:

A number of media outlets, including Reuters and Yahoo! Finance, are covering the release next week of a new Pugatch Consilium authored report on the role played by IPRs in biotechnology research and development.

Commissioned by BIO the report, titled “Taking Stock: the Gains of Global Biotechnology Research from IPRs,” focuses on the extent to which IPRs play a role in encouraging upstream R&D and downstream commercialization in biotechnology. Significantly it provides evidence and case study analysis of the role of ...

Continue Reading →
0

Pugatch Consilium at BIO 2012

Posted by:

Pugatch Consilium are pleased to announce that we will be presenting the findings of a new research report on IPRs and biotechnology at the 2012 BIO convention in Boston, Massachusetts.

The event, Intellectual Property and Biotechnology – The Way Ahead, will be held on June 19th at 2pm. The session will unveil a new report commissioned by BIO and carried out by Pugatch Consilium. The report focuses on the extent to which intellectual property rights (IPRs) play a role in encouraging upstream ...

Continue Reading →
0

EU Directorate General for External Policies and the European Parliament ACTA workshop report released

Posted by:

Earlier this year on March 1 2012 the Directorate General for External Policies and the European Parliament hosted a workshop on the ACTA agreement. Based on his academic work and international expertise in the area of IPRs, international trade and pharmaceuticals, Pugatch Consilium founder and Managing Director Dr Meir Pugatch spoke at the workshop on the ACTA’s potential impact on the international trade of generic medicines.

As part of the workshop Dr Pugatch and Pugatch Consilium Senior Consultant Dr David Torstensson ...

Continue Reading →
0

Supreme Court Ruling – Prometheus v Mayo

Posted by:

Late last month the United States Supreme Court overturned existing patent claims held by Prometheus Laboratories.

The patents in question relate to a test enabling physicians to set levels of medication for treating autoimmune disorders affecting the digestive system. The Court argued that the patents did not in fact do more than describe naturally occurring phenomena, which in themselves are not patentable.

The verdict has raised concerns in the biotechnology industry over future application of the ruling and its implications for lower ...

Continue Reading →
0

Dr Meir Pugatch invited to speak on ACTA and access to medicines by European Parliament

Posted by:

Wide-spread protests against the ACTA in Europe have intensified what was already a heated debate over the treaty and its potential impact in the EU. While protesters have mainly focused on ACTA and the internet, policymakers at both the EU and national level have been examining the treaty’s potential effect on the international trade of generic medicines.

Ensuring access to medicines in middle and low income countries has since the late 1990s been a priority for the international community. The access ...

Continue Reading →
0

R&D Tax Credits – Economic Rationale and Impact

Posted by:

The use of R&D tax credits is a growing area of interest for governments and policymakers around the world seeking to stimulate economic activity and innovation. What is the economic rationale behind the R&D tax credit? What do current tax credits look like within the OECD and G20? And do these tax credits stimulate and attract more R&D investment?

To read more click here

Continue Reading →
0

Microsoft vs. China – who will have the upper hand?

Posted by:

This week saw Microsoft in an unprecedented move launch a number of lawsuits alleging intellectual property infringement against Chinese retailers including electrics and PC giants Shanghai Gome and Buynow.

With the growth of the Chinese PC market – which overtook the American last year as the world’s biggest – Microsoft is clearly worried about the persistent high levels of software piracy in China which, according to the Business Software Alliance, is still close to 80%.

In a bigger picture, the Microsoft lawsuits ...

Continue Reading →
0

Trends for Innovation, Technology Transfer and Pharmaceutical Market Access 2012

Posted by:

With the passing of 2011 and the ringing in of a New Year, we thought it apt to highlight some of the issues we expect to be at the forefront of 2012. Below we have compiled a list of what we think will happen in the upcoming year with regards to the global economy and the world of innovation, intellectual property, technology transfer, and market access.

General Economic and Business Outlook

–         The European debt crisis will continue to hang ...

Continue Reading →
0
Page 4 of 5 12345